In addition, we provide further evidence to support a direct role for caspase-2 in adipocyte biology, fat expansion and its potential as a therapeutic target from the treatment of obesity and metabolic disease. This evidence concerns the gene CASP2 and obesity due to melanocortin 4 receptor deficiency.